T. Minárik

发表

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma.

K. Krejcy, G. Tulunay, J. Šufliarský, 2005, Gynecologic oncology.

Gemcitabine and carboplatin treatment in patients with relapsing ovarian cancer.

J. Šufliarský, A. Dorr, D. Světlovská, 2009, Neoplasma.

Arcanobacterium haemolyticum invasive infections, including meningitis in cancer patients.

J. Šufliarský, J. Trupl, V. Krčméry, 1997, The Journal of infection.

Fluconazol plus ofloxacin in prophylaxis of infections in patients with acute leukemia: a comparative study

J. Mardiak, V. Krčméry, E. Tomasik, 1993, Supportive Care in Cancer.

Nosocomial bacterial and fungal meningitis in cancer patients

J. Šufliarský, S. Špánik, J. Trupl, 1995, Supportive Care in Cancer.

Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients

J. Šufliarský, M. Mego, K. Kalavska, 2018, Journal of Ovarian Research.

Right ventricular septal pacing

M. Táborský, T. Minárik, 2011 .

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

A. Reuss, I. Ray-Coquard, N. Colombo, 2019, International journal of cancer.

Treatment Patterns, Health Care Utilization, and Costs of Ovarian Cancer in Central and Eastern Europe Using a Delphi Panel Based on a Retrospective Chart Review

T. Bozanovic, L. Bodnar, V. Pažin, 2013, International Journal of Gynecologic Cancer.

165 Gemcitabine (G) plus carboplatin (C) in patients whose epithelial ovarian carcinomas (EOC) relapsed ≥ 6 months after platinum-containing first-line therapy: Preliminary results of a phase II study

K. Krejcy, G. Tulunay, J. Šufliarský, 2003 .